STAAR Surgical Company (STAA)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$23.47-0.47%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · STAA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | FY 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | — | 239.4 | 239.4 | 313.9 | 322.4 | 239.4 | 230.5 | 150.2 | 150.2 | 124.0 | 90.6 | 82.4 | 77.1 | 75.0 | 72.2 | 63.8 | 62.8 |
| Total Revenues | — | 239.4 | 239.4 | 313.9 | 322.4 | 239.4 | 230.5 | 150.2 | 150.2 | 124.0 | 90.6 | 82.4 | 77.1 | 75.0 | 72.2 | 63.8 | 62.8 |
| Cost of Revenues | — | 57.0 | 57.0 | 74.3 | 69.8 | 61.0 | 51.8 | 38.2 | 38.2 | 32.4 | 26.3 | 24.1 | 24.4 | 26.2 | 21.9 | 19.5 | 20.4 |
| Gross Profit | — | 182.4 | 182.4 | 239.6 | 252.7 | 223.4 | 178.6 | 112.0 | 112.0 | 91.5 | 64.3 | 58.4 | 52.7 | 48.8 | 50.3 | 44.3 | 42.4 |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | — | 274.1 | 274.1 | 252.2 | 224.6 | 179.6 | 145.3 | 100.1 | 100.1 | 84.9 | — | — | — | — | — | — | — |
| R&D Expenses | — | 40.1 | 40.1 | 54.0 | 40.5 | 36.0 | 33.9 | 25.3 | 25.3 | 22.0 | 20.0 | 20.7 | 14.8 | 12.4 | 6.7 | 6.4 | 5.9 |
| Operating Income | — | (91.7) | (91.7) | (12.6) | 28.1 | 43.8 | 33.3 | 11.9 | 11.9 | 6.6 | (3.6) | (12.7) | (5.3) | (8.0) | 0.7 | (1.2) | 2.8 |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.5 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | 0.1 | 0.0 | 0.1 | 0.1 | 0.2 | 0.5 |
| Other Non-Operating Income / Expenses | — | 9.5 | 9.5 | 3.6 | 5.6 | 1.8 | (2.0) | 1.2 | 1.2 | 0.0 | 1.3 | 0.2 | (0.3) | (0.6) | 0.4 | 0.7 | (0.1) |
| EBT, Incl. Unusual Items | — | (82.3) | (82.3) | (9.1) | 33.7 | 45.6 | 31.3 | 13.0 | 13.0 | 6.6 | (2.3) | (12.4) | (5.6) | (8.6) | 1.1 | (0.5) | 2.7 |
| Income Tax Expense | — | (1.8) | (1.8) | 11.2 | 12.3 | 5.9 | 3.8 | (1.0) | (1.0) | 1.7 | (0.2) | (0.3) | 0.9 | (0.3) | 0.7 | 1.2 | 1.4 |
| Net Income | |||||||||||||||||
| Net Income | — | (80.4) | (80.4) | (20.2) | 21.3 | 39.7 | 27.5 | 14.0 | 14.0 | 5.0 | (2.1) | (12.1) | (6.5) | (8.4) | 0.4 | (1.8) | 1.3 |
| Per Share | |||||||||||||||||
| Basic EPS | — | (1.62) | (1.62) | (0.41) | 0.44 | 0.83 | 0.58 | 0.32 | 0.32 | 0.12 | — | — | (0.17) | (0.22) | 0.01 | (0.05) | 0.04 |
| Diluted EPS | — | (1.62) | (1.62) | (0.41) | 0.43 | 0.80 | 0.56 | 0.30 | 0.30 | 0.11 | — | — | (0.17) | (0.22) | 0.01 | (0.05) | 0.04 |
| Basic Weighted Avg Shares | 50.3 | 49.6 | 49.6 | 49.1 | 48.5 | 48.0 | 47.2 | 44.5 | 44.5 | 42.6 | 41.0 | 40.3 | 39.3 | 38.1 | 36.7 | 36.3 | 35.4 |
| Diluted Weighted Avg Shares | 51.5 | 49.6 | 49.6 | 49.1 | 49.4 | 49.4 | 49.5 | 46.9 | 46.9 | 45.3 | 41.0 | 40.3 | 39.3 | 38.1 | 38.6 | 36.3 | 36.9 |
| Supplemental | |||||||||||||||||
| EBIT | — | (91.7) | (91.7) | (12.6) | 28.1 | 43.8 | 33.3 | 11.9 | 11.9 | 6.6 | (3.6) | (12.7) | (5.3) | (8.0) | 0.7 | (1.2) | 2.8 |
| Effective Tax Rate | — | 2.2% | — | — | 36.6% | 12.9% | 12.1% | -7.8% | -7.8% | 25.2% | 6.8% | 2.5% | -16.6% | 2.9% | 64.3% | -239.7% | 50.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.